Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014

Djingarey Mamoudou H.; Diomande Fabien V. K.; Barry Rodrigue; Kandolo Denis; Shirehwa Florence; Lingani Clement; Novak Ryan T.; Tevi-Benissan Carol; Perea William; Preziosi Marie-Pierre; LaForce F. Marc

首页> 外文期刊>Clinical infectious diseases >Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014

【24h】

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014

机译：2010-2014年在非洲脑膜炎带国家引入和推出新的A组脑膜炎球菌共轭疫苗（PsA-TT）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. A group A meningococcal conjugate vaccine (PsA-TT) was developed specifically for the African "meningitis belt" and was prequalified by the World Health Organization (WHO) in June 2010. The vaccine was first used widely in Burkina Faso, Mali, and Niger in December 2010 with great success. The remaining 23 meningitis belt countries wished to use this new vaccine.

机译：背景。 A组脑膜炎球菌结合疫苗（PsA-TT）是专门为非洲“脑膜炎带”开发的，并于2010年6月获得世界卫生组织（WHO）的资格预审。该疫苗首次在布基纳法索，马里和尼日尔广泛使用在2010年12月取得了巨大的成功。其余23个脑膜炎带国家希望使用这种新疫苗。

著录项

来源
《Clinical infectious diseases》 |2015年第5期|共8页
作者
Djingarey Mamoudou H.; Diomande Fabien V. K.; Barry Rodrigue; Kandolo Denis; Shirehwa Florence; Lingani Clement; Novak Ryan T.; Tevi-Benissan Carol; Perea William; Preziosi Marie-Pierre; LaForce F. Marc;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
meningococcal group A; meningitis belt; Africa; PsA-TT; rollout plan;

机译：脑膜炎球菌A组;脑膜炎带;非洲;PsA-TT;推广计划;

相似文献

外文文献
中文文献
专利

1. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014 [J] . Djingarey Mamoudou H., Diomande Fabien V. K., Barry Rodrigue, Clinical infectious diseases . 2015,第Suppla5期

机译：2010-2014年在非洲脑膜炎带国家引入和推出新的A组脑膜炎球菌共轭疫苗（PsA-TT）
2. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017 [J] . Fernandez Katya, Lingani Clement, Aderinola Olaolu Moses, The Journal of Infectious Diseases . 2019,第Suppla4期

机译：脑膜炎球菌脑膜炎在脑膜炎球菌血清血液中的非洲脑膜炎带爆发术后疫苗介绍，2011-2017
3. Impact of the Meningococcal A Conjugate Vaccine Introduction in the African Meningitis Belt, 2010-2017 [J] . Andre Arsene Bita Fouda American Journal of Biomedical and Life Sciences . 2019,第4期

机译：2010-2017年在非洲脑膜炎带引入脑膜炎球菌A结合疫苗的影响
4. NON-TOXIC ESCHERICHIA C0ULT MUTANTS AND SUPRA-MOLECULAR BIOVECTOR SYSTEM (SMBV~(TM)) FOR INTRANASAL IMMUNIZATION WITH MENINGOCOCCAL CONJUGATED VACCINES [C] . B.C. Baudner, D. Betbeder, O. Balland, International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001

机译：脑膜炎球菌免疫接种的非毒性大肠埃希氏菌突变和超分子生化系统（SMBV〜（TM））
5. The molecular analysis of quinolone-resistant and nonencapsulated Streptococcus pneumoniae after the introduction of new oral fluoroquinolone and pneumococcal conjugate vaccine [D] . TAKEUCHI, Noriko 2019

机译：新型口服氟喹诺酮和肺炎球菌结合疫苗接种后对喹诺酮耐药和非包膜肺炎链球菌的分子分析
6. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries 2010–2014 [O] . Mamoudou H. Djingarey, Fabien V. K. Diomandé, Rodrigue Barry, -1

机译：2010-2014年在非洲脑膜炎带国家引入和推出新的A组脑膜炎球菌共轭疫苗（PsA-TT）
7. Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. [O] . Dominique A Caugant, Paul A Kristiansen, Xin Wang, 2012

机译：在引入血清群a缀合物疫苗之前，来自非洲脑膜炎带的国家的侵袭性脑膜炎球菌分离物的分子特征。

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014

摘要

著录项

相似文献

相关主题

期刊订阅